PETX
Aratana Therapeutics, Inc.
NasdaqGM
People also watch:PTCTOMEDFPRXEPZMXLRN
6.45-0.07 (-1.07%)

After hours: 6.450.00 (0.00%) as of 4:31 PM EDT

Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close6.52
Open6.54
Bid6.15 x 5000
Ask7.50 x 200
52wk Range2.56 - 19.99
Day's Range6.35 - 6.57
Volume337,635
Avg Vol (3m)625,996
As of 4:00 PM EDT. Market closed.
  • Capital Cube24 days ago

    ETF’s with exposure to Aratana Therapeutics, Inc. : July 1, 2016

    Click here to see latest analysis*Disclaimer : This is as of previous day’s closeETF’s with exposure to Aratana Therapeutics, Inc.Here are 5 ETF’s with the largest exposure to PETX-US. Comparing the performance and risk of Aratana Therapeutics, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us […] (Read more...) The post ETF’s with exposure to Aratana Therapeutics, Inc. : July 1, 2016 appeared first on CapitalCube.

  • American City Business Journals25 days ago

    It's a hat trick: Aratana files for third FDA approval

    The Leawood-based animal health company has filed an administrative New Animal Drug Application with the Food and Drug Administration's Center for Veterinary Medicine for the drug Nocita. The therapeutic is administered as a single dose by tissue infiltration during closure of torn knee ligament surgery in dogs. Aratana has received two FDA approvals so far this year, and this application is the company's third.